Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
3,308.70 3,114.30 2,743.30 2,539.30 2,225.10 1,860.10 1,831.40 1,771.50 1,341.20 1,145.44
Revenue Growth
6.24% 13.52% 8.03% 14.12% 19.62% 1.57% 3.38% 32.08% 17.09% 19.33%
Gross Profit
765.00 745.60 647.50 574.90 491.40 379.80 423.80 410.10 327.40 324.24
Operating Income
389.50 348.80 328.00 345.20 302.20 183.00 235.90 77.80 158.30 196.48
EBT
116.90 147.10 135.00 110.30 81.20 (18.80) 54.60 (69.20) 82.30 92.18
Income after Tax
98.90 12.50 135.30 87.00 70.70 1.30 45.10 (95.60) 28.70 85.08
Net Income Common
(77.90) (168.10) (11.90) (54.60) (81.20) (155.60) (110.50) (238.10) (79.10) 9.45
EPS (Diluted)
(0.61) (1.33) (0.09) (0.59) (1.12) (3.19) (2.27) (4.96) (1.64) 0.20
Shares (Diluted, Weighted)
127.21 126.12 125.61 91.95 72.43 48.78 48.28 48.03 48.32 48.19
Gross Margin
23.12% 23.94% 23.60% 22.64% 22.08% 20.42% 23.14% 23.15% 24.41% 28.31%
EBIT Margin
12.46% 11.83% 12.47% 14.09% 14.09% 10.42% 13.44% 4.89% 12.28% 17.57%
Net Profit Margin
(2.35%) (5.40%) (0.43%) (2.15%) (3.65%) (8.37%) (6.03%) (13.44%) (5.90%) 0.83%
Free Cash Flow Margin
7.32% 6.82% 8.41% 3.59% 1.60% 14.11% 4.01% 7.00% 6.81% 7.52%
EBITDA
588.40 520.90 460.30 472.50 412.30 288.60 322.60 154.10 216.60 240.80
EBIT
412.40 368.30 342.20 357.70 313.50 193.80 246.10 86.70 164.70 201.25

Show all line items

In millions of $ except per-share values · columns are period end dates